{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:24:28Z","timestamp":1778516668183,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.braindev.2019.12.010","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T08:09:49Z","timestamp":1579680589000},"page":"256-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Osteoporosis pathology in people with severe motor and intellectual disability"],"prefix":"10.1016","volume":"42","author":[{"given":"Tomoko","family":"Sakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Honzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Kaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2019.12.010_b0005","first-page":"91","article-title":"Fractures in persons with severe motor and intellectual disabilities in institutions: current status and prevention (in Japanese)","volume":"1","author":"Morishita","year":"2006","journal-title":"Care of Persons with Severe Motor and Intellectual Disabilities"},{"key":"10.1016\/j.braindev.2019.12.010_b0010","first-page":"42","article-title":"Report of questionnaire survey (In Japanese)","volume":"15","author":"Morishita","year":"2015","journal-title":"Bull West Jpn Assoc Inst Children Severe Disabil"},{"key":"10.1016\/j.braindev.2019.12.010_b0015","unstructured":"Committee for Developing Guidelines on the Treatment and Prevention of Osteoporosis (Japan Osteoporosis Society, Japanese Society for Bone and Mineral Research, and Japan Osteoporosis Foundation) (In Japanese). Guidelines for the Prevention and Treatment of Osteoporosis 2015. Tokyo: Life Science Publishing; 2015."},{"key":"10.1016\/j.braindev.2019.12.010_b0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1442-200X.2008.02571.x","article-title":"Secondary osteoporosis in long-term bedridden patients with cerebral palsy","volume":"50","author":"Iwasaki","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1016\/j.braindev.2019.12.010_b0025","first-page":"477","article-title":"Effects of a vitamin K2 preparation in severely handicapped patients complicated by osteopenia (in Japanese)","volume":"30","author":"Tsuji","year":"1998","journal-title":"No To Hattatsu (Tokyo)"},{"key":"10.1016\/j.braindev.2019.12.010_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/BPO.0b013e3180317403","article-title":"Fractures in patients with cerebral palsy","volume":"27","author":"Presedo","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.braindev.2019.12.010_b0035","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/13638490600668061","article-title":"The first-generation anti-epilepsy drugs decreases fracture rate in children with cerebral palsy","volume":"9","author":"Stevenson","year":"2006","journal-title":"Pediatr Rehabil"},{"key":"10.1016\/j.braindev.2019.12.010_b0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1469-8749.2009.03384.x","article-title":"Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review","volume":"51","author":"Mergler","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2019.12.010_b0045","first-page":"1552","article-title":"Two cases of children with severe motor and intellectual disabilities treated with bisphosphonates for osteoporosis","volume":"60","author":"Sasaki","year":"2007","journal-title":"Jpn J Pediatr"},{"key":"10.1016\/j.braindev.2019.12.010_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1123\/pes.2017-0217","article-title":"Agreement between dual-energy X-ray absorptiometry and quantitative ultrasound to evaluate bone health in adolescents: the PRO-BONE Study","volume":"30","author":"Torres-Costoso","year":"2018","journal-title":"Pediatr Exerc Sci"},{"key":"10.1016\/j.braindev.2019.12.010_b0055","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00198-014-3012-y","article-title":"Is calcaneal quantitative ultrasound useful as a prescreen stratification tool for osteoporosis?","volume":"26","author":"Thomsen","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.braindev.2019.12.010_b0060","unstructured":"Yamazaki K. Actual QUS equipment using QUS: Osteoporosis Japan 13(1), 24,2005."},{"key":"10.1016\/j.braindev.2019.12.010_b0065","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00198-015-3040-2","article-title":"Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes","volume":"26","author":"Montalcini","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.braindev.2019.12.010_b0070","unstructured":"Nakatuka N, Nishizawa R. Tartrate-resistant acid phosphatase: bone metabolic marker, Medical Review Co., Ltd. P. 73\u201383."},{"key":"10.1016\/j.braindev.2019.12.010_b0075","first-page":"1046","article-title":"Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease","volume":"77","author":"Gamero","year":"1993","journal-title":"J Clin Endocrin Metab"},{"key":"10.1016\/j.braindev.2019.12.010_b0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.2006-1706","article-title":"Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years","volume":"92","author":"Rauchenzauner","year":"2007","journal-title":"J Clin Endocrin Metab"},{"key":"10.1016\/j.braindev.2019.12.010_b0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00774-007-0826-0","article-title":"Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects","volume":"26","author":"Nishizawa","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.braindev.2019.12.010_b0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bone.2018.06.011","article-title":"Clinical utility of bone markers in various diseases","volume":"14","author":"Vlot","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.braindev.2019.12.010_b0095","first-page":"33","article-title":"Skeletal responses to space flight and the bed rest analog: a review","volume":"7","author":"LeBlanc","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.braindev.2019.12.010_b0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.sc.3100665","article-title":"Bone mineral status after pediatric spinal cord injury","volume":"36","author":"Kannisto","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.braindev.2019.12.010_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156991","article-title":"Disrupted bone metabolism in long-term bedridden patients","volume":"11","author":"Eimori","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.braindev.2019.12.010_b0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1385\/JCD:7:2:192","article-title":"Characteristics of long bone DXA reference data in Hong Kong Chinese","volume":"7","author":"Leung","year":"2004","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.braindev.2019.12.010_b0115","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00421-016-3383-1","article-title":"Physical exercise associated with improved BMD independently of sex and vitamin D levels in young adults","volume":"116","author":"T\u00f8nnesen","year":"2016","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.braindev.2019.12.010_b0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00198-014-2840-0","article-title":"Bone mineral density and vitamin D status in ambulatory and non-ambulatory children with cerebral palsy","volume":"26","author":"Finbr\u00e5ten","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.braindev.2019.12.010_b0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jpc.13768","article-title":"Consensus guidelines on the use of bisphosphonate therapy in children and adolescents","volume":"54","author":"Simm","year":"2018","journal-title":"J Pediatr Child Health"},{"key":"10.1016\/j.braindev.2019.12.010_b0130","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/dmcn.13196","article-title":"Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: An update","volume":"58","author":"Ozel","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2019.12.010_b0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1515\/JPEM.2000.13.7.933","article-title":"Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid","volume":"13","author":"Erbayat Altay","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.braindev.2019.12.010_b0140","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.yebeh.2003.11.025","article-title":"Bone health in pediatric epilepsy","volume":"5","author":"Sheth","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2019.12.010_b0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0387-7604(94)90125-2","article-title":"Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children","volume":"16","author":"Chung","year":"1994","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2019.12.010_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2009.10.011","article-title":"Bone and calcium metabolism and antiepileptic drugs","volume":"112","author":"Verrotti","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.braindev.2019.12.010_b0155","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1528-1157.2001.416800.x","article-title":"Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy","volume":"42","author":"Guo","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2019.12.010_b0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pediatrneurol.2007.05.018","article-title":"Bone mineral density with lamotrigine monotherapy for epilepsy","volume":"37","author":"Sheth","year":"2007","journal-title":"Pediatr Neurol."}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760419307181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760419307181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:48:16Z","timestamp":1759952896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760419307181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0387760419307181"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2019.12.010","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis pathology in people with severe motor and intellectual disability","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2019.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}